EMERGING INFECTIOUS DISEASES

Scope & Guideline

Empowering Researchers to Tackle Emerging Diseases

Introduction

Delve into the academic richness of EMERGING INFECTIOUS DISEASES with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1080-6040
PublisherCENTERS DISEASE CONTROL & PREVENTION
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationEMERG INFECT DIS / Emerg. Infect. Dis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 CLIFTON RD, ATLANTA, GA 30333

Aims and Scopes

The journal 'Emerging Infectious Diseases' focuses on the critical study and dissemination of knowledge related to infectious diseases that are newly identified or have reemerged due to various factors. Its scope encompasses a wide range of infectious agents, epidemiology, public health implications, and innovative methodologies for disease prevention and control.
  1. Emerging Infectious Diseases Surveillance:
    The journal emphasizes the importance of surveillance systems for emerging diseases, including zoonotic infections and antimicrobial resistance, to provide timely data for public health interventions.
  2. Epidemiology and Public Health Impact:
    It covers research that evaluates the epidemiology of infectious diseases, assessing their impact on public health and the effectiveness of interventions.
  3. Innovative Diagnostic and Therapeutic Approaches:
    The journal highlights advancements in diagnostics and therapeutics for infectious diseases, focusing on novel technologies and treatment strategies.
  4. Global Health and Policy Responses:
    Research addressing global health policies, responses to pandemics, and the socio-economic factors influencing disease spread and control are key aspects of the journal's focus.
  5. One Health Approach:
    The journal incorporates a One Health perspective, recognizing the interconnectedness of human, animal, and environmental health in the emergence and spread of infectious diseases.
The journal has adapted to the rapidly evolving landscape of infectious diseases, particularly in the wake of the COVID-19 pandemic. Emerging themes reflect a growing interest in interdisciplinary approaches, novel pathogens, and innovative public health strategies.
  1. COVID-19 Research:
    A significant increase in publications related to COVID-19, including its variants, vaccination strategies, and long-term impacts, showcasing the journal's responsiveness to global health crises.
  2. Antimicrobial Resistance Innovations:
    Emerging research on antimicrobial resistance, including novel detection methods and management strategies, reflects heightened global concern over resistant pathogens.
  3. Zoonotic Diseases and One Health:
    Increased focus on zoonotic diseases, emphasizing the One Health approach that integrates veterinary and human health research to address disease emergence.
  4. Digital and Surveillance Technology:
    Research utilizing digital health technologies and innovative surveillance methods has gained traction, highlighting the importance of data-driven responses to disease outbreaks.
  5. Socioeconomic and Behavioral Studies:
    There is a growing emphasis on the socioeconomic factors influencing disease spread and public health responses, addressing health disparities and community engagement.

Declining or Waning

While 'Emerging Infectious Diseases' continues to address a broad spectrum of topics, certain themes have shown a decline in prominence over recent years. These waning scopes reflect shifting priorities in research and public health focus as new challenges emerge.
  1. Traditional Infectious Disease Models:
    There has been a noticeable decline in research focused solely on traditional infectious disease models, as the journal's emphasis has shifted towards real-time data and adaptive responses to outbreaks.
  2. Longitudinal Studies of Established Diseases:
    Long-term studies on well-established infectious diseases like tuberculosis are less frequently published, possibly due to a shift towards urgent emerging threats.
  3. Vector Control Studies:
    Research specifically targeting vector control strategies has seen reduced emphasis, potentially overshadowed by broader discussions on integrated disease management.
  4. Single-Pathogen Focus:
    The journal is moving away from studies that focus exclusively on single pathogens, favoring research that examines co-infections and the complex interactions between multiple pathogens.

Similar Journals

Infectious Diseases

Connecting Scholars in the Battle Against Infectious Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

Biosafety and Health

Shaping the future of health with impactful discoveries.
Publisher: ELSEVIERISSN: 2096-6962Frequency: 6 issues/year

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

Open Forum Infectious Diseases

Transforming insights into impactful practices.
Publisher: OXFORD UNIV PRESS INCISSN: 2328-8957Frequency: 12 issues/year

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

LANCET INFECTIOUS DISEASES

Unraveling Complexities in Infectious Disease Science
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Eurosurveillance

Advancing global health through open access research.
Publisher: EUR CENTRE DIS PREVENTION & CONTROLISSN: 1025-496XFrequency: 50 issues/year

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

EPIDEMIOLOGY AND INFECTION

Pioneering Insights for Infectious Disease Management
Publisher: CAMBRIDGE UNIV PRESSISSN: 0950-2688Frequency: 1 issue/year

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Transforming understanding of infectious diseases worldwide.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Mediterranean Journal of Infection Microbes and Antimicrobials

Advancing knowledge in infection and microbiology.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Transboundary and Emerging Diseases

Exploring the frontiers of transboundary disease science.
Publisher: WILEY-HINDAWIISSN: 1865-1674Frequency: 1 issue/year

Welcome to Transboundary and Emerging Diseases, a prestigious journal published by WILEY-HINDAWI. With its ISSN of 1865-1674 and E-ISSN of 1865-1682, this journal plays a pivotal role in the dissemination of high-quality research within the fields of Immunology, Microbiology, Medicine, and Veterinary Sciences. Based in the United Kingdom, this open-access journal stands out with a remarkable impact factor, reflecting its category quartiles in 2023, where it secured Q1 rankings across multiple disciplines, including a remarkable rank of #3 out of 194 in Veterinary General, placing it in the top 2% of its field. With coverage spanning from 2008 to 2024, Transboundary and Emerging Diseases provides a vital platform for researchers, professionals, and students to explore emerging threats to global health and animal welfare. The journal's commitment to open access ensures broad availability of cutting-edge research, fostering collaboration and knowledge sharing in pursuit of innovative solutions to transboundary diseases. Join a community dedicated to advancing the science and practice within this crucial area of study.

China CDC Weekly

Exploring the forefront of epidemiology and infectious diseases.
Publisher: Chinese Center for Disease Control and PreventionISSN: 2096-7071Frequency: 52 issues/year

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.